The myriad ways digital tools could change everything for pharma and the NHS
Our Mobile Health is on a mission to build confidence in digital health by assessing and curating high-quality health apps. CEO Julie Bretland tells us what the company looks for in a good app and how digital health can change the industry
Feat.: Making health apps a reality; Brexit and the supply chain; Patiet-centric sales
Why medical affairs is the most important role in the future of pharma
Biosimilars may have proven their worth, but how can adoption be sped up?
Pharma comms is one of the most dynamic sectors of the industry. So, what should be on communicators’ radar?
The all new Sales Awards offers a unique opportunity for sales professionals at all levels of their career to sharpen their skills and showcase their talents industry-wide.
16th July 2018
The PharmaTimes Marketer of the Year competition offers a unique opportunity for all marketers, from aspiring to experienced, to sharpen their skills and showcase their talents against marketing professionals, industry-wide.
16th July 2018
Sobi UK and Ireland has announced the launch of Kineret across the country offering a new treatment option for Adult Onset Stills Disease (AOSD) and Systemic-Onset Juvenile Idiopathic Arthritis (SJIA).
16th July 2018
AstraZeneca’s biologic Fasenra will likely be funded on the NHS as a treatment for people with severe eosinophilic asthma.
16th July 2018
US regulators have approved the first treatment designed to mitigate the impact of a potential outbreak of smallpox caused by bioterrorism.
16th July 2018
How data trends in the financial services sector could transform pharma
A new report looks into how medtech must address key problems
Blockchain technology could be game-changing for electronic medical records, but new GDPR rules need to be taken into account
Seeking success in value-based healthcare
Katie Ruane was just 22 when diagnosed with CML, and while drugs keep the disease in remission it still takes a huge toll on her life
NHS England’s assurance process provides a window of opportunity for pharma – but communication and joint working with the health service is key
The failure of several Alzheimer’s drug trials in the past year has dampened, but not destroyed, hopes for a cure
Home DNA tests are now common, but using genome sequencing to personalise drugs still has some way to go
The regulatory impacts of Brexit could be far-reaching, so now is not the time to take a ‘wait and see’ approach
The myriad ways digital tools could change everything for pharma and the NHS
Our Mobile Health is on a mission to build confidence in digital health by assessing and curating high-quality health apps. CEO Julie Bretland tells us what the company looks for in a good app and how digital health can change the industry
Patient-centred healthcare is here to stay, so how can pharma sales embrace it?
Simon Grime, director of Fendix, explains how pharma can utilise its wealth of existing resources and content to improve collaboration with the NHS online
Peter Cherry, PhD, Medmeme’s vice president, information systems, explores how pharma can identify predatory journals and conferences
The importance of a patient-centric focus to improve the real-world use of medicine was extensively discussed during the 3rd Annual Patient Engagement and Experience Conference (16–17th May 2018, Amsterdam, Netherlands).
Medical conferences provide one of the most valuable opportunities for pharma to engage with key stakeholders, but until recently, it was extremely difficult to gather and analyse relevant information from conference data
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
